LMB In The News

Greg Winter and the promise of antibody-based therapies

In conversation with the FEBS Journal, Greg discusses his early motivations, monoclonal antibody therapy research, life after the Nobel prize, and balancing entrepreneurship with science. He also lets in on a secret childhood fantasy, “As a boy I fancied being the captain of tramp steamer plying the South Pacific…”. More


Madeline Lancaster explains brain organoids to The Times

Simon Crompton of The Times interviews Madeline about her early experience when growing mini brains in the lab and the journey towards insights into human brain development and what fundamentally sets us apart from animals (story behind paywall). More…


Benjamin Falcon discusses his research in Neuronet’s first newsletter

LMB’s newly recruited Group Leader weighs in on various aspects of Alzheimer’s Disease, from the clinical implications of deciphering Tau filaments in brains of people suffering from neurodegenerative diseases, to designing precise drugs. More


Two LMB scientists shortlisted for Cambridge Independent’s ‘Researcher of the Year’ award

This year’s Science and Technology Awards, run by Cambridge’s weekly newspaper, feature Benjamin Falcon from Neurobiology Division and Julius Fredens from Protein and Nucleic Acid Division as finalists. The ‘Researcher of the Year’ winner, out of a shortlist of six, will be announced at an awards ceremony at the Bradfield Centre. More…


What is the best time for a heart surgery?

And why does it matter? BBC writes about the role circadian rhythms plays in how our bodies respond to injuries, infections and healing, including work by John O’Neill’s group on tissue repair damage and biological time. More…


Financial Times features Madeline Lancaster in ‘Masters of Science’ 2019

Financial Times Logo

How are mini brains revolutionising neuroscience? FT’s annual scientific feature series visits the LMB and Madeline’s lab to trace the rapid development in the field since 2011 when Madeline pioneered the field of cerebral organoids and insights into mechanisms of some diseases. More…


In The Economist, Madeline Lancaster and the rise of cerebral organoid research

The Economist Logo

The Economist draws on the evolution of the first cerebral organoids in Madeline Lancaster’s lab in 2013 to today’s research on electrical impulses from these mini brains. It discusses the fast pace of development in this scientific field and poses future research questions. More


Jason Chin and synthetic proteins in Wired

Roger Highfield, Science Director of the Science Museum Group and a member of the Medical Research Council, writes about Jason and his team’s work at the LMB focusing on “turbocharging the ribosome”. Jason explains the process behind evolving new ribosomes and it marks a revolution in our ability to evolve, manufacture and discover polymer sequences. More


At the Hay Festival: Venki Ramakrishnan discusses how science is done

hay festival logo

Venki Ramakrishnan talks to Adam Rutherford about science as a microcosm of humanity, and the roles of competition, collaboration and altruism within it. To a packed audience, he explains the ribosome and how LMB’s focus on basic fundamental research pushes such transformative science. You can listen to it free online (this week only). More…


LifeLab and me: from the research lab to the pop-up lab!

LifeLab logo

Shahana Ahmed, a research assistant in the LMB’s PNAC Division, describes why she does public engagement and her experience of talking about science in shopping centres at LifeLab last year. More…